Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Eagle Pharmaceuticals Files For Mixed Shelf Of Up To $200M

– SEC Filing

byBenzinga Newsdesk

October 11, 2022

1 minute read

– SEC Filing

Truist Securities Initiates Coverage On Burlington Stores with Buy Rating, Announces Price Target of $350

By Benzinga Newsdesk

Today, 3:40 AM

Truist Securities analyst Beth Reed initiates coverage on Burlington Stores (NYSE:BURL) with a Buy rating and announces Price Target of $350.

BURL

B of A Securities Maintains Buy on Toll Brothers, Raises Price Target to $70

By Benzinga Newsdesk

Today, 3:40 AM

B of A Securities analyst Rafe Jadrosich maintains Toll Brothers (NYSE:TOL) with a Buy and raises the price target from $68 to $70.

TOL

Investors Bancorp: Q4 Earnings Insights

By Benzinga Insights

Today, 3:40 AM

Investors Bancorp (NASDAQ:ISBC) reported its Q4 earnings results on Wednesday, January 26, 2022 at 05:00 PM. Here's what investors need to know about the announcement.

ISBC

Benchmark Initiates Coverage On GoDaddy with Buy Rating, Announces Price Target of $102

By Benzinga Newsdesk

Today, 3:40 AM

Benchmark analyst Mark Zgutowicz initiates coverage on GoDaddy (NYSE:GDDY) with a Buy rating and announces Price Target of $102.

GDDY

Eagle Pharmaceuticals Files For Mixed Shelf Of Up To $200M

Related Posts

Truist Securities Initiates Coverage On Burlington Stores with Buy Rating, Announces Price Target of $350

B of A Securities Maintains Buy on Toll Brothers, Raises Price Target to $70

Investors Bancorp: Q4 Earnings Insights

Benchmark Initiates Coverage On GoDaddy with Buy Rating, Announces Price Target of $102